-+ 0.00%
-+ 0.00%
-+ 0.00%

WINDWARD BIO: FIRST PHASE 3 STUDY OF WIN378 HAS BEEN INITIATED EVALUATING TWO, TWICE-YEARLY DOSES; SECOND PHASE 3 TRIAL PLANNED TO BEGIN H1 2027

路透·09/08/2026 12:10:44

登录查看新闻详情